SAVAYSA® (edoxaban) Dosing | HCP
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - - Clinical Pharmacology in Drug Development - Wiley Online Library
Hokusai-VTE Clinical Trial | SAVAYSA® (edoxaban) | HCP
Edoxaban - wikidoc
Overview of edoxaban dose adjustment criteria. | Download High-Quality Scientific Diagram
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation | NEJM
Anticoagulation therapy in Atrial Fibrillation patients at high bleeding risk
Edoxaban: A New Oral Factor Xa Inhibitor Anticoagulant
EDOXABAN
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries - European Journal of Internal Medicine
Edoxaban - wikidoc
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation | Journal of the American College of Cardiology
SAVAYSA® (edoxaban) Dosing for Patients | HCP Site
SAVAYSA® (edoxaban) Dosing | HCP
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology
Efficacy Endpoints of Low Dose Edoxaban Strategy | Download Table
Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement
Missouri Society of Health-System Pharmacists - Pharmacist Continuing Education: From DOACs to ROACs: Strategies for Reversing Oral Anticoagulants
